id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0475-0028,FDA,FDA-2007-N-0475,"Attachment 1 - ""Post Hoc Analysis of Studies SPD426-401 and SPD426-404"" - [Shire Pharmaceuticals - Information and Data] re FDA-2007-N-0475-0027",Supporting & Related Material,INFO-Information (Supporting and Related Material),2010-10-04T04:00:00Z,2010,10,,,2010-10-04T23:48:45Z,,0,0,0900006480b64871
FDA-2007-N-0475-0030,FDA,FDA-2007-N-0475,"Attachment 4 - ""Edward Nieshoff, MD - Correspondence"" - [Shire Pharmaceuticals - Comment] re FDA-2007-N-0475-0027",Supporting & Related Material,C-Comment (Supporting and Related Material),2010-10-04T04:00:00Z,2010,10,,,2010-10-04T23:49:10Z,,0,0,0900006480b648eb
FDA-2007-N-0475-0029,FDA,FDA-2007-N-0475,"Attachment 3 - ""Statistical Analysis - Edward Nieshoff, MD - Unpublished Results with Midodrine in Spinal Cord Injury"" - [Shire Pharmaceuticals - Comment] re FDA-2007-N-0475-0027",Supporting & Related Material,C-Comment (Supporting and Related Material),2010-10-04T04:00:00Z,2010,10,,,2010-10-04T23:49:08Z,,0,0,0900006480b648e9
FDA-2007-N-0475-0019,FDA,FDA-2007-N-0475,Proposal to Withdraw Marketing Approval/Notice of Opportunity for Hearing - Letter,Other,LET-Letter,2010-08-16T04:00:00Z,2010,8,2010-09-14T04:00:00Z,,2016-01-30T20:41:02Z,,0,0,0900006480b31b83